Clinical trial registry record

Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated December 14, 2015.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02132091
Last registry update
December 14, 2015
Status
Completed
Phase
Phase not reported
Sponsor
University of Florida
Enrollment
37
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · CROSSOVER · BASIC SCIENCE · QUADRUPLE
Evidence population
Human clinical study registration
Participants
37
Population
ALL · 19 Years to 30 Years
Duration
2011-03-01 to 2011-11-01
Intervention
Intermittent Fasting; 400 IU Vitamin E; 1000 mg Vitamin C
Comparator
Not reported
Outcomes measured
SOD2 gene expression (intermittent fasting) — 3 weeks; SOD2 gene expression (antioxidant supplementation) — 3 weeks; GPx1 gene expression (intermittent fasting) — 3 weeks; SIRT1 gene expression (intermittent fasting) — 3 weeks; SIRT3 gene expression (intermittent fasting) — 3 weeks; mTFA gene expression (intermittent fasting) — 3 weeks; NRF1 gene expression (intermittent fasting) — 3 weeks; 8oxodG ratio (intermittent fasting) — 3 weeks; 8oxoG ratio (intermittent fasting) — 3 weeks; GPx1 gene expression (antioxidant supplementation) — 3 weeks; SIRT1 gene expression (antioxidant supplementation) — 3 weeks; SIRT3 gene expression (antioxidant supplementation) — 3 weeks; mFTA gene expression (antioxidant supplementation) — 3 weeks; NRF1 gene expression (antioxidant supplementation) — 3 weeks; 8oxodG ratio (antioxidant supplementation) — 3 weeks; 8oxoG ratio (antioxidant supplementation) — 3 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Caloric restriction · 100%Title contains controlled term: intermittent fasting. Abstract contains controlled term: intermittent fasting. Source terminology contains: intermittent fasting. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
  • Oxidative stress · 80%Title contains controlled term: oxidative stress. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.